Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda symbols : RVNC save search
U.S. FDA Approves First Therapeutic Indication for Revance’s DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia
Published: 2023-08-14 (Crawled : 13:00) - biospace.com/
VTRS | News A | $11.55 1.67% 1.65% 4.4M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: -1.06%
RVNC | $3.57 -2.46% -2.52% 1.8M
|
Health Technology
|
| O: 6.13%
H: 1.54%
C: -3.04%
daxxify fda treatment injection
Brand Institute Partners on Brand Name and Nonproprietary Name Development for FDA Approved Injection for Frown Lines
Published: 2022-09-12 (Crawled : 14:20) - biospace.com/
RVNC | $3.57 -2.46% -2.52% 1.8M
|
Health Technology
|
| O: 1.33%
H: 0.49%
C: -2.63%
fda approved injection
Revance Announces FDA Approval of DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection, the First and Only Peptide-Formulated Neuromodulator With Long-Lasting Results
Published: 2022-09-08 (Crawled : 18:00) - biospace.com/
VTRS | News A | $11.55 1.67% 1.65% 4.4M
|
Health Technology
|
| O: -0.57%
H: 0.83%
C: 0.16%
RVNC | $3.57 -2.46% -2.52% 1.8M
|
Health Technology
|
| O: 18.79%
H: 3.03%
C: 2.35%
fda approval
Revance Receives FDA Acceptance of BLA Resubmission for DaxibotulinumtoxinA for Injection for Glabellar Lines
Published: 2022-04-21 (Crawled : 01:00) - biospace.com/
RVNC | $3.57 -2.46% -2.52% 1.8M
|
Health Technology
|
| O: 2.13%
H: 0.0%
C: 0.0%
fda resubmission injection
Revance Resubmits Biologics License Application for DaxibotulinumtoxinA for Injection for Glabellar Lines to the FDA
Published: 2022-03-08 (Crawled : 14:00) - biospace.com/
RVNC | $3.57 -2.46% -2.52% 1.8M
|
Health Technology
|
| O: -1.98%
H: 9.58%
C: 6.34%
fda application xin license label injection
Revance Receives Clarity on Path to Resubmission of the BLA for DaxibotulinumtoxinA for Injection Following Type A Meeting with FDA
Published: 2022-01-18 (Crawled : 01:00) - biospace.com/
RVNC | $3.57 -2.46% -2.52% 1.8M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
fda xin injection submission resubmission
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.